HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harrison Parry Dilworth Selected Research

Myofibroma

5/2005Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harrison Parry Dilworth Research Topics

Disease

1Cicatrix (Scar)
05/2005
1Fasciitis (Fascitis)
05/2005
1Fibroma (Fibromatosis)
05/2005
1Fibrosarcoma
05/2005
1Leiomyosarcoma
05/2005
1Neoplasms (Cancer)
05/2005
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
05/2005
1Sarcoma (Soft Tissue Sarcoma)
05/2005
1Dermatofibrosarcoma
05/2005
1Myofibromatosis
05/2005
1Myofibroma
05/2005

Drug/Important Bio-Agent (IBA)

1Formaldehyde (Formol)FDA Link
05/2005
1ParaffinIBA
05/2005
1beta CateninIBA
05/2005